Hey Maui, I very seldom post, and it is because I do not

New Post Public Reply Private Reply Replies (3) Message Board
DandyRitter Mauibound #3600
Hey Maui,

I very seldom post, and it is because I do not want people to misunderstand and even possible accuse me of pumping or bashing. Trust me, I am neither. As stated, I have been a shareholder or watching AMBS since it was below a penny. Unfortunately, I did not buy when it was under a penny (kicked myself many times for not) but at that time they did not have the catalyst they have today. But I did buy under a nickel and have bought many times, watching it go to almost .20 twice and come back down. I have never doubted the investment until the last few weeks.....and still not saying it is bad, but as Tanis or someone said, I am now sleeping with one eye open

To answer some of your questions, it may appear I am a basher, which I am not. However, I will give some general remarks as I do not want to go and dig up the exact quotes and dates as honestly, I do not have time, and it will not add anything to this board. GC did say on more than one occasion that he did not see a need for dilution. Around that time he was saying that we might can uplist without a reverse split, or at least it was a possibility. When I said 3 out of 4 tests were not close to being complete, I was referring to the fact that some of them did not even have the number of participants needed to conduct the tests. This came directly from GC. When I say GC might be pumping without his realization, it is from the above statements I am referring. He might be better just saying nothing instead of getting shareholders excited about news or results that may or may not happen or be available. When I remarked that I am now wondering if we will get any upfront money from our partner, you don't have to be too smart to realize that if we were going to get 30-50M in cash, then the extra shares would not be needed. If we just want to protect from a hostile takeover, there are ways to attach voting rights to shares that will take care of that and will not potentially increase dilution. Now these remarks make me seem like a basher.....and again, I am not, but do have concerns.

To also sound like a pumper, I am very confident we will have a Lympro partner. I thought it was going to be Quest but J&J is still viable possibility. Either would be excellent and I think we would see a large jump in SP immediately. I think Retinitis (spelling) is a lot bigger deal than we on the board have discussed. That is a homerun if it works! Would put money on the table and make MANF in much greater demand. I truly like that GC communicates as I am invested in countless other stocks and get almost zero communication. Lincoln Financial did not agree to invest 20M without knowing something we do not know....period. Last, you do not build a management team at the level AMBS has without having a solid product with great potential.

So, hopefully you will see I am not a pumper or basher, but simply a concerned shareholder. I would like nothing more than to see AMBS grow 1000% and I think it can happen. I just do not want to see us go through 5 generations of shareholders and have a lot of ill will in the process. We have some very intelligent posters on this board who do a lot of good DD. Hopefully good news coming that will let me sleep with both eyes closed!!! GLTA

Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

AI Tool Identifies PTSD in ER: Game-changer?

Updated Category News Views 79

Pushing Boundaries: AI and Emergency Room Narratives When you think about the chaos of an emergency room, PTSD might not be the first thing that comes to mind. But for the folks developing cutting-edge AI at NYU Langone Health, it's a crucial window of opportunity. Enter PREVIA, an AI tool that’s been tapping into patients’ narratives to pinpoint PTSD risks with...

Continue Reading
Entegris Acquires Advanced Abrasives: A Sector Shift

Updated Category News Views 28

Entegris Expands Its Footprint in High-Tech It's clear as daylight—Entegris is making moves with its latest acquisition of Advanced Abrasives Corporation. With Advanced Abrasives’ reputation for serving the semiconductor and high-tech industries with precision abrasives, Entegris is likely aiming to strengthen its already substantial presence across multiple global...

Continue Reading
FFR's OmniMind Takes Top Spot In RoboColiseum Rankings

Updated Category News Views 353

The AI Race Heats Up with FFR's Big Win Stop the presses—FFR's OmniMind AI just snagged the top spot on RoboColiseum's global rankings. Yeah, you heard right, this ain't just some run-of-the-mill news. As of November 6, they've parked themselves in pole position, beating out heavyweights like NVIDIA's GR00T N1.7 and GPT-6 Astra. That's like hitting a grand slam right...

Continue Reading
NAMSA, AMS Partner to Fast-Track Tissue-Healing Tech

Updated Category News Views 57

Streamlining the Path to Market I tell you, the medical device sector is no walk in the park these days. Between the regulators breathing down your neck and the endless red tape, getting a new product from the lab to the hospital floor can feel like running a marathon in quicksand. That's why this deal between NAMSA and Advanced Medical Solutions (AMS) has me taking a...

Continue Reading
Korean 'Glocal' Districts Entice U.S. Tourists with Local Flavor

Updated Category News Views 164

Gwangju's Dongmyeong-dong is like the neighborhood artists and hipsters flock to in New York—except it’s got a Korean twist. Nestled in the Jeonnam region, this place is hot on American tourists' radar for its spicy mix of local culture, unique eats, and shops that scream individuality. It's becoming a magnet for folks who want to get a taste of Korean life but with a...

Continue Reading
Higer Buses Debut in UK: Expansion on Full Throttle

Updated Category News Views 100

Shifting Gears in the UK: Higer Enters the Fray You don't just waltz into the UK's bus and coach market without making some serious noise. Well, Higer is doing just that at Euro Bus Expo 2026. Birmingham's NEC turned into a stage for their showdown, where they unveiled three models: Azure 9, V12, and V10. The star of the show, the Azure 9, is tailored just for the Brits,...

Continue Reading
Tigo Energy Faces Class Action: Investor Deadline Looms

Updated Category News Views 69

Unpacking Tigo's Rollercoaster: Lawsuit & Market Reaction They sometimes say, "When it rains, it pours." For Tigo Energy, it’s been more a downpour than a drizzle. Here we are, chasing down what's going on with Tigo Energy (NASDAQ:TYGO), fresh off the heels of a class action fuss that's grabbed every investor's attention. If you've got a stake, or even a passing...

Continue Reading
Vandelay's Steadfast Support for St. Jude Amid Growth

Updated Category News Views 47

Vandelay's Philanthropic Journey Hats off to Vandelay Companies. They’re marking eight years of standing strong with St. Jude Children’s Research Hospital. That's like a solid partnership in today’s business landscape, especially when you’re juggling over 2,000 team members and 32 properties. As they expand their restaurant portfolio across the U.S., they haven't...

Continue Reading
Innovative Eyewear Powers Ahead with 51% Revenue Boost

Updated Category News Views 35

Big Gains and Bigger Moves Ahead Here's a bit of sunshine for your investment portfolio: Innovative Eyewear's third-quarter results are packing quite the punch, showing a strong 51% uptick in revenue year-over-year. If you've got a stake in NASDAQ:LUCY, pay close attention. This ain't just a flash in the pan; it's a consistent rise, marking their 13th consecutive quarter...

Continue Reading
Invitation Homes Supports Veterans in Skilled Trades Push

Updated Category News Views 64

A New Chapter for Veterans in the Workforce Normally when a company kicks off a partnership, it’s all about fluff and show. But this thing with Invitation Homes and the Home Builders Institute (HBI) is the real deal for veterans looking to switch gears into new careers. The objective is simple—get transitioning service members, veterans, and their families rolling...

Continue Reading

Top 5 Most Recently Viewed Articles

TGS ASA Engages Fixed Income Investors for Key Meetings

Updated Category News Views 137

TGS ASA Engages in Important Fixed Income Investor Meetings Oslo, Norway – TGS ASA, a pioneering force in energy data and intelligence, is preparing to engage with fixed income investors over a series of meetings. Scheduled to commence on a Monday, these meetings will see participation from notable institutions including J.P. Morgan, Danske Bank, and DNB Markets,...

Continue Reading
Man Group PLC's Disclosure on Urban Logistics REIT plc Holdings

Updated Category News Views 135

Understanding Man Group PLC's Recent Disclosure In the world of finance, transparency is key. This recent announcement from Man Group PLC serves as a public opening position disclosure concerning Urban Logistics REIT plc. It highlights the interests and positions held by a person in the relevant securities that are 1% or greater, adhering to Rule 8.3 of the Takeover Code....

Continue Reading
Understanding the Shift in Employer Attitudes Towards Talent

Updated Category News Views 221

Understanding the Shift in Employer Attitudes Towards Talent A recent survey unveiled significant insights into hiring practices and employer attitudes regarding overqualified candidates. Employers often welcome these candidates, yet they harbor deep concerns about retention and engagement, which leaves many job seekers feeling anxious. This changing perspective...

Continue Reading
GeneDx Reports Q4 Earnings: Analysts React with Price Cuts

Updated Category News Views 218

Unpacking the Earnings Surprise Can’t say I didn’t see that one coming. GeneDx (NASDAQ:WGS) drops some profits like it’s hot for Q4, clocking in earnings of 14 cents per share. That’s a solid beat compared to the 11-cent consensus the suits on Wall Street were whispering about. You can’t shake a stick at that, right? Well, not so fast—because the stock took a...

Continue Reading
Investing in Freeport-McMoRan: A 10-Year Perspective

Updated Category News Views 197

A Deep Dive into Freeport-McMoRan's Journey Alright, let’s cut to the chase. Freeport-McMoRan (NYSE: FCX)—this name's been buzzing on the trading floor for a while now. If you had put down $100 in FCX stock a decade ago, buckle up—your investment would be sitting pretty at about $859.11 today. That’s quite the leap, huh? In a market that shifts gears faster than a...

Continue Reading